Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis

LM Yonker, Z Swank, YC Bartsch, MD Burns, A Kane… - Circulation, 2023 - Am Heart Assoc
Background: Cases of adolescents and young adults developing myocarditis after
vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–targeted …

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

A Alami, D Krewski, N Farhat, D Mattison, K Wilson… - BMJ open, 2023 - bmjopen.bmj.com
Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …

[HTML][HTML] COVID-19 vaccines and myocarditis: an overview of current evidence

A Hromić-Jahjefendić, A Sezer, AAA Aljabali… - Biomedicines, 2023 - mdpi.com
COVID-19 vaccines have been widely used to reduce the incidence and disease severity of
COVID-19. Questions have lately been raised about the possibility of an association …

[HTML][HTML] Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine

M Schmeling, V Manniche… - European journal of …, 2023 - Wiley Online Library
Vaccination has been widely implemented for mitigation of coronavirus disease-2019 (Covid-
19), and by 11 November 2022, 701 million doses of the BNT162b2 mRNA vaccine (Pfizer …

[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities

K Bardosh, A Krug, E Jamrozik, T Lemmens… - Journal of Medical …, 2024 - jme.bmj.com
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …

[HTML][HTML] COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated …

K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips… - Vaccine, 2024 - Elsevier
Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients

T Nakahara, Y Iwabuchi, R Miyazawa, K Tonda… - Radiology, 2023 - pubs.rsna.org
Background Patients who developed myocarditis after SARS-CoV-2 vaccination show
abnormalities on cardiac MRI scans. However, whether myocardial changes occur in …

[HTML][HTML] Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self …

J Stowe, E Miller, N Andrews, HJ Whitaker - PLoS Medicine, 2023 - journals.plos.org
Background An increased risk of myocarditis or pericarditis after priming with mRNA
Coronavirus Disease 2019 (COVID-19) vaccines has been shown but information on the risk …

Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis

FTT Lai, EWW Chan, L Huang, CL Cheung… - Journal of the American …, 2022 - jacc.org
Background Association between messenger RNA (mRNA) COVID-19 vaccines and
myocarditis has aroused public concern over vaccine safety. Objectives The goal of this …

COVID-19 mRNA vaccination and myocarditis or pericarditis

A Husby, L Køber - The Lancet, 2022 - thelancet.com
In April, 2021, international news media first reported rare cases of young men in Israel who
had developed myocarditis shortly after vaccination with the Pfizer-BioNTech mRNA vaccine …